|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Alkermes Inc., of Cambridge, Mass., and Eli Lilly and Co., of Indianapolis, reported the results of a single-dose Phase I trial in which an inhaled formulation of human growth hormone based on Alkermes' AIR technology demonstrated acceptable pulmonary bioavailability, achieved dose equivalence to subcutaneous injection of human growth hormone and was well tolerated. The preliminary findings were presented at the 14th International Society for Aerosols in Medicine conference in Baltimore.
o Altana Pharma AG, of Bad Homburg, Germany, said it netted $22 million after selling its two product lines to KV Pharmaceutical Co., of St. Louis. Its Chromagen and ...